sign in sign up
<<
Home , Male accessory gland, Polyorchidism, Webbed penis

Subject Index

[ [ A2M, see 2-macroglobulin ALA, see -linolenic acid anorgasmia 102, 105, 503 AAS, see anabolic-androgenic steroid albumin 419 antegrade ejaculation 37 AAV, see adeno-associated virus alcoholism 58, 349 anti-ageing 565 aberrant mammary tissue (AMT) 235 alfuzosin 540 –products624 ABP, see androgen-binding protein allergic contact dermatitis 198 antiandrogen 21 [ accessory gland infection 78 allodynia 172 1-antichymotrypsin (ACT) 417 Achenbach questionnaire 610 Alzheimer’s disease 252 anti-doping rules 556 acne 622 amantadine 54 anti-Müllerian hormone (AMH) 266, acquired immunodeficiency syndrome amenorrhoea 469 269, 305, 410, 458 (AIDS) 131, 331, 586 AMH, see anti-Müllerian hormone anti-oestrogen 518 – testicular atrophy 333 amitriptyline 174 antioxidant 46, 573, 625 acquired testicular damage 66 ammonia dermatitis 207 antisperm antibody (ASA) 31, 44, 47, acromegaly 76 amniocentesis 65 154, 298 acrosin 389, 392 amoxicillin 73 Apert syndrome 473 acrosomal hypoplasia 399 AMP, see adenosine monophosphate apomorphine 285, 530 acrosome reaction 50, 276, 301 AMT, see aberrant mammary tissue apoptosis 294 [ ACT, see 1-antichymotrypsin anabolic steroid 75, 87 appendix testis 140 ACTH, see adrenocorticotropin anabolic-androgenic steroid (AAS) AR, see androgen receptor acute 555 ARCT, see ATP release cytotoxicity – appendicitis 145 – abuse 557 test – bacterial prostatitis 218 anaerobe 403 areolar sebaceous hyperplasia 233 –epididymitis145 analbuminaemia 419 arginine 575 – scrotum 138, 139, 145 analogue assay 409 aromatase 410 ––surgery 146 anastomosis 341, 503, 507 – inhibitor 240, 518 – urinary infection 217 androgen 21, 28, 77, 226, 516, 555 ART, see assisted reproduction technol- ADAM – deficiency 359, 376 ogy – family 301 –derivatives517 arterial flow 339 – score 552 – insensitivity syndrome (AIS) 23, artificial insemination with husband’s Addison’s disease 563 270, 310 semen (AIH) 11 adeno-associated virus (AAV) 66, 126 – – partial form (PAIS) 270 ASA, see antisperm antibody adenosine – receptor (AR) 242, 270, 367 ascorbic acid 625 – diphosphate (ADP) 392 –sideeffects22 aspermatogenesis 296 – monophosphate (AMP) 392 androgen-binding protein (ABP) 261, aspermia 54, 359 – triphosphate (ATP) 48, 392 278 assisted reproduction technology ––release cytotoxicity test (ARCT) 48 andrology (ART) 586, 572, 610 adjuvant hormonal ablation therapy – consent form for treatment 10 astaxanthin 574 545 – cost-effectiveness 7 asthenozoospermia 31, 77 ADP, see adenosine diphosphate – definition 1 atherosclerosis 340, 526 ADPKD, see autosomal dominant poly- – evidence-based medicine 5 atopic dermatitis 199 cystic kidney disease – international development 2 atrophy 151, 152 [ -adrenergic blocking agent 215 – tumour markers 415 ATRX, see alpha-thalassaemia-mental- adrenocorticotropin (ACTH) 310, 562 androstenedione 243 retardation-X-linked aesthetic andrology 621, 632 anejaculation 35, 359 autoimmune orchitis 122, 295 AFP, see alpha fetoprotein – obstructive 100 autosomal dominant polycystic kidney ageing 250, 561 aneuploidy in cell 354 disease (ADPKD) 437 –oftheskin623 Angell’s sign 142 average life expectancy 565 agenesis of the epididymal tail 432 Angelman syndrome 302 AZF, see azoospermia factor agglutination test 48 angina 217 azoospermia 58, 64, 115, 116, 187, AHA, see alpha-hydroxy acid angiodynography 144 343, 351, 433, 454, 522 AIDS, see acquired immunodeficiency angiogenesis 420 – factor (AZF) 582 syndrome angioleiomyoma 234 – non-obstructive 81, 465 AIH, see artificial insemination with angioma senile 233 – obstructive 81, 432, 470 husband’s semen 413 636 Subject Index

bacterial infection 73, 323 carnitine 569 complex regional pain syndrome 172 balanitis 191, 206, 404 – L-carnitine 574 compulsive sexual behaviour (CSB) –circinata194 CASA, see computer-assisted semen 109 – circumscripta plasmacellularis 193, analysis computer-assisted semen analysis 194 catheterization 510 (CASA) 389 – xerotica obliterans (BXO) 206 cavernosal concealed penis 620 balanoposthitis 191, 192, 206, 210 –artery 339 congenital basal cell carcinoma (BCC) 234 – blood gas value 167 – adrenal hyperplasia (CAH) 23 BCC, see basalcellcarcinoma cavernosography 88, 165 ––salt-wastingform 24 Beckwith Wiedemann syndrome 473 CBAVD, see congenital bilateral ab- – anorchia 410 bell-clapper deformity 135, 136, 150 sence of the – bilateral absence of the vas deferens benign hyperplasia (BPH) CC, see clomiphene citrate (CBAVD) 83, 433, 470 213, 252, 416 centrifugation 117 contact thermography 448, 451 – brachytherapy 215 cephalosporin 73 continuous wave Doppler (CW) 437 – radical prostatectomy 215 cervical mucus 300 contraception – radiotherapy 215 cervicitis 330 – condoms 123 – therapy 535 cervonic acid 572 – periodic abstinence 123 – watchful waiting 539 CFU, see colony forming unit – traditional methods 122 bicalutamide 226, 547 CGA, see chromogranin A – withdrawal 123 biggerexia 557 Char syndrome 235 controlled ovarian hyperstimulation bioflavonoid 222 chemical (COH) 580 bladder neck function 101 –browlift628 cord bladder outlet obstruction (BOO) – peeling 630 – denervation 175 538, 540 chlamydia (C.) 73, 221, 325, 329, 378 –hydrocele181 bladder overactivity 376 –infection129 – torsion 344 bleomycin 186 – pneumoniae 330 cordyceps sinensis 569 blockade of nerve 174 – trachomatis 45, 328, 330, 403, 406 corpora 491 [ -blocker 222, 254, 540 cholestasis 559 – cavernosa 264, 265 blood- barrier 297 chondroitin sulphate 569 corpus spongiosum 264, 265 blood-testis barrier (BTB) 276, 294 208 corticosteroid 548 blunt testicular trauma 162, 163 –tissue94 –therapy50 body mass index (BMI) 34, 60, 226 chromatid 274 cortisol 562 bone chromatin 330, 398 corynebacterium spp. 403 – alkaline phosphatase 418 –stability45 cosmeceutical 624 – density 552 chromogranin A (CGA) 418 cost-effectiveness 7 BOO, see bladder outlet obstruction chromosomal abnormality 63, 463 counting chamber 388 borrelia burgdorferi infection 233 chronic pain syndrome 171, 177, 495 Cowper’s gland 264, 382 botulinum toxin A 626, 630 chronicpelvicpainsyndrome 218 COX2, see cyclooxygenase-2 –application627 [ -chymotrypsin 46 craniopharyngioma 76 brain death 13 Cialis 88 crataegus 569 BRCA gene 238 203 crater defect syndrome 399 breast cancer 527 –inadults489 creatine phosphokinase (CK) 392 – in men 228 –neonatal204 cremasteric breeding bull syndrome 599 – psychological consequences 209 –artery 260 bromelain 46 –ritual207 – reflex 141, 142 BTB, see blood-testis barrier –sexual209 – spasm 136 Buck’s fascia 164 – wound infection 207 Crohn’s disease 217 bupivacaine 485 cirrhosis 238 crow’s feet 629 buserelin 546 CIS, see carcinoma in situ cryobanking 586 BXO, see balanitis xerotica obliterans cisplatin 186 cryobiology 586 CK, see creatine phosphokinase cryoinjury 587 cachexia 556 C-KIT 369 cryopreservation 406, 585 cadmium 352 clomiphene 579 cryostorage 588 caffeine 349, 587 – citrate (CC) 558, 583 55, 78, 150, 154, 187, CAIS, see complete androgen insensi- clonal selection 364 267, 297, 311, 343, 427, 428, 458, 472 tivity syndrome clostridium botulinum 626 cryptozoospermia 31 cAMP, see cyclic adenosine monophos- CMV, see cytomegalovirus –idiopathic77 phate c-myc gene 367 CSB, see compulsive sexual behaviour cancer counselling 603 coaxial catheter 510 Cushing’s disease 412 candida albicans 126 COH, see controlled ovarian hyper- CVD, see cardiovascular disease capacitation 300 stimulation CW, see continuous wave Doppler capillary force 452 coitus interruptus 123, 383 cycle of spermatogenesis 279 carbon disulfide 353 colchicine 54 cyclic adenosine monophosphate carcinoma collagen 631 (cAMP) 587 – erysipelatoid 235 Collins knife 221 cyclooxygenase-2 (COX2) 567 – in situ (CIS) 368 colony forming unit (CFU) 388 cyclophosphamide 548 – – of the testis 187 complete androgen insensitivity syn- cyproterone acetate 21, 533, 547 cardiovascular disease (CVD) 251 drome (CAIS) 310 cystic fibrosis 59, 64, 470, 471, 475 Subject Index 637

– transmembrane conductance regula- – agonist 315 end diastolic velocity (EDV) 439 tor (CFTR) 33, 83, 465, 470, 603 doping 556 endocrine disorder 408 cytochrome P450C17 309 – control 559 endorphin 176 cytokine 153, 294, 323 Doppler technique 437 endothelin 340 cytomegalovirus (CMV) 404 dosage-sensitive sex reversal (DSS) endotoxaemia 221 cytosine methylation 473 269, 308 enterobacteriaceae spp. 403 cytoskeleton 473 Down’s syndrome 463, 475 enterococcus (E.) spp. 403 doxazosin 541 entrapment neuropathy 171 daidzein 566 doxycycline 73 enzyme-linked immunosorbent assay dartos pouch fixation 148 DRE, see digitalrectalexamination (ELISA) 49, 409 DAX-1, see DSS-ACH critical region on drosophila EPA, see eicosapentaenoic acid the X chromosome –arizonae472 epididymal DAZ gene 467 – mojavensis 472 – cyst 429, 487 DBCP, see dibromochloropropane dry skin 623 ––excision 488 DDT, see dichlorodiphenyltrichloroe- DSS, see dosage-sensitive sex reversal ––ultrasound 445 thane DSS-ACH critical region on the X chro- – tumour 445 decapitated spermatozoa 399 mosome (DAX-1) 269 epididymectomy 174, 175, 488 deferent duct 433 ductal carcinoma 238 epididymis 45, 66, 72, 74, 120, 260, degloving incision 165 ductus deferens 262 297, 373, 406 dehydroepiandrosterone (DHEA) Dupuytren’s contracture 93, 94 – adenomatoid tumour 181 243, 562, 563 Düsseldorf classification 396 – cyst 181 Denys-Drash syndrome 268, 307 dysplasia 269 –neoplasm181 deoxyribonucleic acid (DNA) 302, dysuria 72, 142, 329 – obstruction 432 462 –tuberculosis182 –methylation473 EAA, see European Academy of Andro- epididymo-orchitis 66, 67, 139, 144, – mutations 465 logy 170, 174, 329 –quality30 EAO, see experimental autoimmune or- epididymovasostomy 501 – repair enzymes 625 chitis epispadia 35, 64, 361 –content463 E-cadherin 367 erectile – proviral 332 echography 69 – deficiency 36 depression 252 EDF, see European Dermatology Forum – deformity 65, 93 dermatofibroma 235 EDO, see ejaculatory duct obstruction – – minor degrees of lateral devia- dermatovenereology 1 EDV, see end diastolic velocity tion 95 DES, see diethylstilbestrol efferent duct 260 – – severe deformity 95 detorsion 153 egg – dysfunction (ED), see also detumescence 165, 167 – donation 12, 611 impotence 1, 167, 168, 252, 254, DHA, see docosahexaenoic – sharing 611 284, 339, 438, 528 DHEA, see dehydroepiandrosterone eicosapentaenoic acid (EPA) 573 ––drugs 85 DHEAS, see DHEA-sulphate ejaculate volume 100 ––endocrine 86 DHEA-sulphate (DHEAS) 243 ejaculation 285 ––genetransfer 596 DHT, see dihydrotestosterone –delayed99 ––neurogenic 86 DI, see donor insemination –ejection286 – – psychogenic problems 87 diabetes mellitus 60, 75 – emission 286 – – vascular disease 92 diakinesis 274 – medications 360 ––vasculogenic 86 diathermy 486 – painful 100 – function 360 dibromochloropropane (DBCP) 351 – premature 99, 360, 374, 531 –rigidity375 dichlorodiphenyltrichloroethane – rapid 531 erection, neuropharmacology 282 (DDT) 316, 354 – retarded 531 erection, bent 375 diethylstilbestrol (DES) 548 – retrograde 100, 359 erotic stimulus 282 diff-quick 395 ––neurogenic 101 erythroplasia de Queyrat 370 digital rectal examination (DRE) 213, ejaculatory duct obstruction (EDO) Escherichia coli 126, 205, 218, 221, 416, 537 37, 82 378 dihydrotestosterone (DHT) 242, 270, ejaculatory dysfunction 31, 99, 359 eSET, see elective single embryo transfer 411, 540, 557 elective single embryo transfer ethical issue 9 dioxin 252 (eSET) 583 European Academy of Andrology direct MAR test 386 electroejaculation 37, 39, 103 (EAA) 2 disomy 464 electromagnetic radiation 350 European Dermatology Forum – of chromosome 21 475 ELISA, see enzyme-linked immunosor- (EDF) 2 DNA, see deoxyribonucleic acid bent assay exhibitionism 111, 112 docosahexaenoic acid (DHA), see also embolization exocytosis 301 cervonic acid 572, 573 –varicocele510 EXONS 462 donor embryo experimental autoimmune orchitis – gamete 613 – donation 612, 614 (EAO) 296 – insemination (DI) 607, 608 ––psychosocialaspects 613 external beam radiation therapy 545 – – life-table analysis 609 –manipulation13 – – pregnancy rates 609 –research12 fallopian tube obstruction 119 – sperm 607 –transfer612 Family Health International (FHI) 498 dopamine 287 embryonic stem cell 614 fas gene 369 638 Subject Index

fatty acid 78, 573 – instability 364 HE, see human epididymis FBC, see female breast cancer – polymorphism 364 headache, vasculogenic orgasm-associ- fecundability 40 –test482 ated 107 female genistein 566 heart failure 252 – breast cancer (FBC) 229 genital hemizona test 390 –fertility – cancer 208 hepatitis – – stress conditions 598 – tract infection 128 –C 196 – genital mutilation (FGM) 210 – ulcer disease (GUD) 209 – virus 404 – infertility 598 genitourinary tract infection 126 hepatocyte growth factor 324 – sterilization 499 genomic imprinting 302 heptachloroepoxide (HCE) 316 female-to-male transsexual germ cell tumour 455 hereditary prostate cancer 481 – hormonal treatment 526 GGT, see gamma-glutamyl transpepti- hermaphroditism 306 fertility 40 dase hernia 54 –ofthemale5 GH, see growth hormone –repair78 fetishism 111 giant condyloma 193 herniorrhaphy 55 [ -fetoprotein (AFP) 184, 418 Gilbert-Dreifuß syndrome 310 herpes simplex virus 404 FGM, see female genital mutilation glabellar wrinkle 627 –infection126 FHI, see Family Health International glans penis 265 heterotopic sebaceous gland 190 fibroma pendulans 233 globozoospermia 399 hexachlorobenzene (HCB) 316 fibromuscular stroma 262 glucosamine sulphate 569 hexavalent chromium 353 fibrosis 87 [ -glucosidase 82 HFEA, see Human Fertilization and finasteride 222, 230 glutaraldehyde 455 Embryo Authority fine needle aspiration (FNA) 230, 582 glutathione 392 HH, see hypogonadotrophic hypogona- Finlay-Marks syndrome 236 glyceryl trinitrate (GTN) 89 dism fixed drug eruption 197 gonadal hidden penis 620 flagellum 275 – development 305 highly active antiretroviral therapy fluoroquinolone 222 – dysgenesis 307 (HAART) 226 5-fluorouracil 202 –sex266 high-quality scientific research 6 flutamide 547 gonadotrophin 77, 314, 517, 583 HIV, see human immunodeficiency virus FNA, see fine needle aspiration gonadotrophin releasing hormome Hodgkin’s disease 59, 604 folic acid 568, 574 (GnRH) 27, 288, 289, 412 homocysteine level 568 follicle-stimulating hormone (FSH) – agonists 522 hormonal 27, 244, 277, 288, 290, 516, 573 – immunoneutralization 522 – contraceptive forehead wrinkle 628 gonococcus 325 ––testosterone 521 , see also prepuce 205, 287 gonorrhoea 129, 329 – reassignment 525 – ballooning 207 Gore-Tex 96 – – side-effects 526 – retraction 210, 489 goserelin 546 hormone 53 four-specimen-test 405, 406 gram-negative bacteria 405 –antagonist53 Fowler-Stephens orchiopexy 344 growthhormone(GH)inageing – determination 408 fPSA, see free PSA men 562 – replacement 612 Frasier syndrome 307 growth hormone-IGF1 axis 562 –therapy19 free PSA (fPSA) 417 GTN, see glyceryl trinitrate HOS, see hypo-osmotic swelling free testosterone 409 GUD, see genital ulcer disease HPV, see human papilloma virus frenuloplasty 490 gynaecomastia 225, 238, 377, 559 HSDD, see hypoactive sexual desire dis- funiculus spermaticus 261 – fatty type 227 order – fine needle aspirates 230 5-HT1A receptor inhibitor 103 gabapentin 174 –lumptype227 human chorionic gonadotrophin galactorrhoea 87 – mammography 229 (hCG) 58, 184, 243, 412, 419 gamete 614 – radiotherapy 230 human dignity 10 gamma interferon 391 gynogenesis 303 human epididymis (HE) 261 gamma-glutamyl transpeptidase Human Fertilization and Embryo (GGT) 390 HAART, see highly active antiretroviral Authority (HFEA) 13 gardnerella (G.) vaginalis 403 therapy human immunodeficiency virus gas chromatography 559 haematocele 163 (HIV) gender haematococcus pluvialis 574 – infection 57, 131, 209 – dysphoria 19, 524, 605 haematoma 374, 439 – – ethical issues 333 – – juvenile 527 haematospermia 67, 374, 382 ––oftheman 334 – gap 251 haematoxylin-eosin 188 ––ofthewoman 334 gene haematuria 67, 374 – occupational transmissions 132 –therapy haemocytometer method 383, 387 – transmission 331 – – corrective 594 haemophilus (H.) ducreyi 403 human papilloma virus (HPV) 201, – – ethical issues 593 haemorrhage 137, 145, 207, 542 331, 370 – – non-viral vectors 593 haemostasis 490 Huntington’s chorea 465, 466 – – viral vectors 593 halo sign 144 hyaluronic acid 631 – transfer 592, 593 HCB, see hexachlorobenzene hydrocele 142 genetic HCE, see heptachloroepoxide – communicating 181 – counselling 602, 603 bhCG, see human chorionic gonadotro- – excision of the tunica vaginalis 487 – imprinting 473 phin – of testis 486 Subject Index 639

–ofthecord181 infection of male accessory sex lactate dehydrogenase (LDH) 421 – sclerotherapy 179 glands 391 lactotroph adenoma 527 – surgery 486 inferior vena cava (IVC) 447 laer energy 542 hydrostatic pressure 450 infertility 2 lamina propria 272 [ -hydroxy acid (AHA) 624 – definition 29 laser treatment 631 17 q -hydroxyl ester 555 – endocrine causes 412 late onset hypogonadism 253 3 q -hydroxysteroid dehydrogenase (3 q - – history 372 latex allergy 123 HSD) 269 inflammation of the pelvic organ 323 LDH, see lactate dehydrogenase 17 q -hydroxysteroid dehydrogenase infrapubic approach 492 LDL, see low-density lipoprotein (17 q -HSD type 3) 269 181 lead 352 hyperalgesia 172 inguinoscrotal surgery 485 leak-proof anastomosis 503 hypercholesterolaemia 251, 340 inhibin B 290, 410, 421, 573 leiomyoma 233 hypergonadotropism 76 insemination 45, 609 leiomyosarcoma 181 hyperoestrogenism 377 – of donor semen (DI) 11 lepidium meyenii 575 hyperprolactinaemia 76, 86, 226, 227, – with husband’s semen 11 leptin 100 315, 358, 411, 532 insulin 228 leptotene 274 hypersexuality 109 interleukin 72, 295 lespedeza bicolor 569 hypertension 252 internal spermatic vein (ISV) 447 leukocyte 332 hyperthermia 57 International Index of Erectile Func- leukocytospermia 325, 405 – of the scrotum 341 tion (IIEF) 85 leukaemia 59 hypoactive sexual desire disorder International Prostate Symptom Score leuprolide 546 (HSDD) 108 (IPSS) questionnaire 536 levitra 88 hypoandrogenism 45, 246, 377 23 levobupivacaine 177, 485 hypogonadism 60, 76, 187, 332, 358 – abnormality 369 Leydig cell 259, 266, 289, 315, 412, – hypergonadotrophic 82 – classification 24 413, 516 – hypogonadotrophic 82, 313 –prenataldiagnosis25 – density 342 hypo-osmotic swelling (HOS) 580 –XY24 – hyperplasia 429 – testing 385 intracavernosal injection 530 – neuroendocrine regulation 245 hypospadia 93, 97, 311, 316, 361, 377 intracytoplasmic sperm injection (ICSI) LH, see luteinizing hormone hypospermatogenesis 83, 457 12, 65, 581 LHRH, see luteinizing hormone releas- hypothalamic-pituitary-gonadal axis – risks 475 ing hormone 311, 558 intrauterine insemination (IUI) 8, 50, libido 358 hypothalamo-pituitary axis 440 79, 132 – abnormality 107 hypothalamo-pituitary-testicular intravaginal latency time (IELT) 99 lichen (HPT) axis 75, 313 intravaginal torsion (IVT) 134 – planus 196 hypothyroidism 315 INTRONS 462 – sclerosus et atrophicus 193 hypoxanthine 344 involuntary infertility 373 Li-Fraumeni syndrome 481 hypoxia 155, 450 ionizing radiation 365 lignans 574 ipsilateral fixation 150 lignocaine 485 ichthyosis 233 IRMA, see immunoradio-active assay [ -linolenic acid (ALA) 573 ICSI, see intracytoplasmic sperm injec- irradiation 55 linum 566 tion ischaemia 138, 342, 343 lipectomy 231 IELT, see intravaginal latency time ischaemia-reperfusion injury 343 lipid peroxidation 344 IFMA, see immunofluorometric assay ischiocavernosus muscle 264 lipoic acid 567 IgG direct MAR test 386 isolated seminal plasma abnormality lipomastia 225 IIEF, see International Index of Erectile 44 litigation 176 Function ISV, see internal spermatic vein Littre’s gland 288 IL1 beta 220 IUI, see intrauterine insemination liver cirrhosis 59 immotile cilia syndrome 399 IVC, see inferior vena cava lobular carcinoma 238 immunobead test 49, 386 IVF, see in vitro fertilization local nerve blockade 174 immunofluorometric assay (IFMA) IVT, see intravaginal torsion LOH, see loss of heterogeneity 409 long terminal repeat (LTR) 365 immunoglobulin 508 Jaboulay’s operation 179 Lord’s procedure 179, 486 – binding test 48 Juberg-Marsida syndrome 308 loss of heterogeneity (LOH) 364 immunoradio-active assay (IRMA) low-density lipoprotein (LDL) 553 409 kallikrein 575, 587 lower urinary tract symptom (LUTS) immunosuppression Kallmann’s syndrome (KS) 75, 314, 89, 220, 252, 529 –theory 47 410, 465 LTR, see long terminal repeat –therapy58 karyotype abnormality 63 Lubs syndrome 310 immunotherapy 594 ketoconazole 28, 548 lumpectomy 239 impotence, see also erectile kidney stone formation 499 luteinizing hormone (LH) 27, 289 dysfunction 360, 361 KIT, see tyrosine kinase receptor gene –secretion impotentia ejaculationis 599 Klinefelter syndrome (47XXY) 63, 83, – – altered regulation 244 in vitro fertilization (IVF) 5, 8, 12, 65, 228, 237, 267, 305, 376, 378, 410, 463, luteinizing hormone releasing hor- 330, 462, 581, 608 464, 482 mone (LHRH) 20, 288, 517 incest 112 Koch’s postulate 218 LUTS, see lower urinary tract symptom induratio penis plastica 426 Koebner phenomenon 195 lycopene 368 infarction 137 KS, see Kallmann’s syndrome lymph node metastasis 184 640 Subject Index

lymphadenectomy 202 mammography 239 MPA, see medroxyprogesterone acetate – prophylactic 203 manganese 353 MPOA, see medial preoptic area lymphadenosis benigna cutis 233 manual detorsion 146 MTOC, see microtubule organizing lymphocyte 293 MAR, see mixed antiglobulin reaction centre lymphoma 181 marital counselling 600 Müllerian cyst 435 marker surge 420 Müllerian inhibiting hormone (MIH) MAB, see maximal androgen blockade mast cell 293 269 [ 2-macroglobulin (A2M) 417 mastectomy 239, 559 Müllerian utricular cyst 436 macro-orchia 378 mastitis 232 multiple pregnancy 583 macrophage 293 mastopathy 227 mumps 57, 67, 374 – migration-inhibitory factor (MIF) maturation arrest 83 – orchitis 145 296 maximal androgen blockade (MAB) – virus 125 MAGI, see male accessory gland infec- 216, 547 muscle dysmorphia 557 tion maximum life expectancy 249 mycobacterium (M.) MAIS, see minimal androgen insensi- MBC, see male breast cancer – leprae 125 tivity meatal ulcer 207 – smegmatis 193, 403 maldescensus testis 64 meatitis 207 – tuberculosis 125, 403 male medial preoptic area (MPOA) 286 mycoplasma 330, 403 – accessory gland infection (MAGI) medical-aesthetic procedure 625 72, 82, 322, 406 medicolegal litigation 155 naevoid hyperkeratosis 233 – adnexitis 406 medroxyprogesterone acetate (MPA) NAT, see neoadjuvant therapy – breast cancer (MBC) 227, 237, 235 522, 533 natural killer (NK) cell 293 – – fine needle aspiration biopsy 239 megalospermatocyte 457 neisseria (N.) gonorrhoeae 402, 406 – – mastectomy 239 meiosis 293, 469 neoadjuvant therapy (NAT) 546 ––surgery 239 melanocytic naevus 234 nerve-sparing retroperitoneal lymph – contraceptive 121 melatonin 290, 561, 562 node dissection (RPLND) 185 – counselling 599 melomental fold 629 Nesbit operation 96 – factor infertility 358 meningioma 76 neuronal nitric oxide synthase –fertility Menkes disease 466 (nNOS) 283 – – iatrogenic causes 53 mercury 353 nifedipine 54 – – lifestyle factors 349 MESA, see microsurgical epididymal nilutamide 547 – – pesticides 351 sperm aspiration nipple – – radiation 350 metabolic syndrome 251 – absence 236 – – smoking 349 metal welding 353 – discharge 233 – – systemic diseases 57 metastase 76 – piercing 232 – – workplace 350 methionine 567 –reconstruction236 – genital aesthetic 617 methyl nitric oxide 340 – glandular tissue 226 – ether 353 nitrospray inhaler 89 – infertility 2, 348 – mercury 353 NM, see nodular melanoma – – aetiology 33 metronidazole 331 nNOS, see neuronal nitric oxide syn- ––antispermantibodies 49 microdeletion 470 thase – – gene transfer 595 microorganism 125, 401 no scalpel vasectomy 496 – – infections 125 – cryptic 220 NO synthase (NOS) 597 ––IUI 579 – fastidious 220 nocturnal – – IVF/ICSI 579 – nonculturable 220 –erection282 – – lifestyle 572 64, 267 – peniletumescence(NPT) 531 – – nutritional factors 572 microprolactinoma 411 nodular melanoma (NM) 234 – – semen analysis 381 microsurgical epididymal sperm aspi- non-Hodgkin lymphoma 59, 420 ––sexualdysfunction 35 ration (MESA) 102, 581 nonseminoma 185 – – stress 599 microtubule organizing centre – germ cell tumour (NSGCT) 419 – – varicocele 450 (MTOC) 301 normozoospermia 315 – 270, 271 MIF, see macrophage migration-inhibi- nortestosterone 557 – reproductive toxicant 348 tory factor NOS, see NO synthase – reproductive tract infections 126 MIH, see Müllerian inhibiting hormone NPT, see nocturnal penile tumenscence – sexual dysfunction 358 Millin’s prostatectomy 542 NSGCT, see nonseminoma germ cell tu- – sexual function 281 minimal androgen insensitivity mour –skin (MAIS) 310 nuclear protein 275 ––type 622 mitochondria 473 nutcracker phenomenon 340 – – shaving 624 mixed antiglobulin reaction (MAR) – sterilization 114 385 OAT, see oligo-astheno-teratozoospermia – 265 –test48 obesity 60 – urogenital tract mixed atrophy 456 obstruction of the vas deferens 119 – – normal flora 401 mixed germ cell tumour 431 obstructive azoospermia 432, 440 ––pathogens 401 Mohs’ microsurgical technique oestradiol 242, 300, 410, 517 male-to-female transsexual 605 (MMT) 202 oestrogen 20, 21, 78, 226, 411, 525, – hormonal therapy 525 Mondor’s disease 191 546 mammary malignant melanoma 234 Montgomery’s tubercle 233 – hypothesis 316 mammillary eczema 232 moxysilate 89 oily skin 622 Subject Index 641 oligo-astheno-teratozoospermia peak systolic velocity (PSV) 438 phenoxybenzamine 540 (OAT) 280, 450, 581 pearly penile papule 190 phentolamine 89, 530 oligozoospermia 8, 31, 41, 43, 58, 69, pelvic phenylephrine 168 311, 315, 433, 457, 465, 516, 581 –kidney471 36, 85, 98, 201, 361, 370, –idiopathic77 – pain 218, 324 377,0 490, 537 oocyte penectomy 202, 619 –pathological205 –activation301 penile – recurrent 207 – donation 610 – abnormality 63, 40 phosphodiesterase type 5 (PDE5) 284 – – counselling 611 – amputation 619 – cardiovascular system 529 – – screening 611 – arterial bypass surgery 530 – inhibitor 98, 528 oral progestin 522 – augmentation surgery 618 –therapy37 orchalgia 170, 174 – cancer 201, 202, 369, 445 phthalate 354 orchidopathy 154 – contact dermatitis 198 phyto-oestrogen 367 orchiectomy 147, 147, 149, 153, 163, – corpus cavernosum 596 PIA, see proliferative inflammatory atro- 175, , 181, 188, 240, 342, 485, 489, 546 –elongation phy orchiodynia 170 – – V-Y plasty 618 PIN, see prostate intraepithelial neopla- orchiopexy 65, 66, 137, 147, 148, 153, –erection282 sia 489 – fracture 164 pinus maritima 569, 575 orchitis 66, 67, 298, 373, 406 ––ultrasound 444 pituitary disease 87 orgasm ––US 445 pityrosporum ovale 199 – dysfunction 105 – implant 530 PLA, see poly-L-lactic acid – painful 102, 105 –infection192 placental-like alkaline phosphatase – reduced intensity 105 – length 617 (PLAP) 420 – unwanted multiple 105 –lesion192 plasma oestradiol 243 osteoporosis 253, 254 –lichenplanus197 plexus pampiniformis 262 OTA, see oligoasthenoteratozoospermia – lymphoedema 208 PMDS, see persistent Müllerian duct ovulation 609 – pain syndrome 223 syndrome oxidative stress 342, 343 – plaque 426 point mutation 465 oxido-reductase ubiquinone Q10 568, – prosthesis 90, 95, 491, 597, 168 pollakisuria 72 574 – psoriasis 195 poly-L-lactic acid (PLA) 631 oxygen radical 565 –sensation375 polychlorinated biphenyl (PCB) 249, – squamous cell carcinoma 482 252, 318, 354 PADAM, see partial androgen deficien- – surgery 95, 485 – congener 317 cy of the aging male –tumour polycythaemia 553 paedophilia 111, 112 – – Jackson staging 202 polymerase chain reaction (PCR) 220 Paget’s disease 234 – – TNM classification 202 – hybridization 131, 332 pain –ulceration198 137 – acute testicular 170 penis 264 polythelia 235 – ice-pick-like 106 – atopic eczema 199 POMC, see proopiomelanocortin – neuropathic origin 170 – cumarin-induced necrosis 198 poor man’s test 219 – nonscrotal 142 – drug-induced lesions 198 positive predictive value (PPV) 448 – orgasm-related 106 – enlarging procedures 94, 618 positron emission tomography – penile 165 –erection85 (PET) 441 – postvasectomy 173 –gangrene208 post void residual (PVR) 538 – prophetic 142 – inflammatory dermatoses 190 posthitis 206 – syndrome 172 – sclerosing lymphangitis 191 postmassage urine 222 –testicular170 penoscrotal approach 492 postvasectomy PAIS, see partial AIS pentoxifylline 587 – orchalgia 182 palindrome 467 percutaneous epididymal sperm aspi- – pain 172, 501, 508 pampiniform plexus 450 ration (PESA) 582 – pain syndrome (PVPS) 115, 117 PAP, see prostatic acid phosphatase periorbital wrinkle 629 – semen analysis 115 papaverine 89, 284,530 peroxidase-positive cell 385 potassium para-aminobenzoate 97 papilloma virus 365, 404 persistent Müllerian duct syndrome PPV, see positive predictive value paraesthesia 172 (PMDS) 311 Prader orchiometer 378 paraphilia 110–112, 533 perversion 112 Prader-Willi syndrome 302, 314 paraphimosis 206 PESA, see percutaneous epididymal prednisolone 548 – recurrent 210 sperm aspiration pregnancy, smoking 349 paraplegia 37, 39 pesticide 318, 319, 351 Prehn’s sign 143 paraventricular nucleus (PVN) 286 PET, see positron emission tomography preimplantation genetic diagnosis parotitis 374 peumus boldus 569 (PGD) 464 pars prostatica 265 Peyronie’s disease 1, 86, 93, 94, 361, preleptotene 274 partial androgen deficiency of the age- 377, 426, 491 prenatal adoption 612 ing male (PADAM) 246 PGD, see preimplantation genetic diag- preprostatic segment 263 paternal RNA 474 nosis prepuce (foreskin) 205, 265, 287 pathogens of the urogenital tract 323 pH paper 382 pressure-flow study 538 PCB, see polychlorinated biphenyl phallic reconstruction 619 priapism 89, 166 PCR, see polymerase chain reaction phalloplasty 619 –arterial167 PDE5, see phosphodiesterase type 5 phenotypic sex 267 – colour Doppler 442 642 Subject Index

– injection therapy 168 puberty 27, 69, 317 scilla maritima 569 –ischaemic167 –delayed28 sclerotherapy 514 – prosthesis insertion 168 – precocious 27 SCO, see Sertoli cell only syndrome – shunt surgery 168 – pseudoprecocious 27 scrotum 259, 264 PRL, see prolactin pubic hair 376 – haematoma 67 proacrosin 389 pudendal – hyperthermia 341 probability of conception per month 40 –nerve282 – incision 163 processus vaginalis 179 ––entrapment 223 –induration143 progesterone 21 – neuralgia 218 – operation 484, 485 progestin 21, 121 pulsed Doppler 437 – skin redundancy 620 prolactin (PRL) 85, 105, 244, 290, 358, puresperm 334 – swelling 162, 180, 379, 487 391, 411 purse-string suture 236 – temperature 448 prolactinoma 86 PVN, see paraventricular nucleus – – sedentary work position 349 proliferative inflammatory atrophy PVPS, see postvasectomy pain syn- – ultrasonography (US) 425 (PIA) 366 drome seborrhoeic proopiomelano-cortin (POMC) 235 PVR, see post void residual – eczema 199 prostaglandin 89, 94, 284 pyospermia 333 – keratosis 234 –E1530 pyrexia 143 sebostasis 199 prostate 262 seed oil 574 – acid phosphatase (PAP) 415 quercetin 222 selective serotonin uptake inhibitor –biopsy543 questionnaire 380 (SSRI) 103 – cancer 213, 214, 253, 318, 366, 441, selenium 367, 567 481, 499, 527 radiation 350 semen 43 – – bone isotope scanning 544 radiotherapy, interstitial 545 – analysis 3, 31, 153, 381 – – bone pain 548 RBM, see RNA binding motif – – postvasectomy 114 – – gene therapy 594 reactive oxygen species (ROS) 126, – biochemical tests 390 – – immunotherapy 594 249, 325, 392, 572 – centrifugation 117 – – metastatic 216 rear tip extender (RTE) 492 – cryopreservation 115, 588 ––PSA-negative 418 reduced sperm count 352 – culture 388 – – radical prostatectomy 593 5 [ -reductase – cytomorphological analysis 395 – – radiotherapy 593 – activity 243 – freezing 608 – – spinal cord compression 548 – inhibitor 215, 254 – sample 36, 381 – – therapy 535 reflex semenogelin 264 – – TNM classification 544 –erection282 seminal – gland 379, 390 – vasoconstriction 154 –plasma44 – intraepithelial neoplasia (PIN) 366 Reiter’s syndrome 194 – – isolated abnormalities 44 – massage 222 renal transplantation 58 – vesicle 263, 380, 390 – stem cell antigen (PSCA) 418 reperfusion 138 seminiferous – zonal anatomy 214 reproductive medicine – 273, 278 prostatectomy 215, 539, 542, 604 – evidence-based medicine 5 – tubules 259, 272, 456 – radical 545 – randomized trials 6 seminoma 183, 185, 430, 431 prostate-specific antigen (PSA) 8, 44, reproductive toxicant 348 semi-rigid prosthesis 494 213, 253, 263, 325, 367, 415, 417, 481, rete testis 260 senile dementia 252 537 retrograde sensitive skin 623 – blood test 214 – ejaculation 37, 187, 359 sentinel lymph node biopsy 239 prostate-specific membrane antigen – – treatment 38 septum pectiniforme 265 (PSMA) 418 – urethrography 165 Serenoa repens 539, 566 prostatitis 72, 74, 101, 172, 217, 318, –venography70 serotonin 287 325, 405 rhabdomyosarcoma 181 – reuptake inhibitor (SSRI) 287 –acute221 ribonuclease L gene (RNASEL) 367 Sertoli cell 275, 276, 277, 456, 458, 516 – experimental 221 ribonucleic acid (RNA) – hypofunction 342 – infective 221 – binding motif (RBM) 467 – Sertoli cell only syndrome (SCO) prostatodynia 217 – recognition motif (RRM) 467 83, 279, 297, 589 prostatovesiculitis 126 righttoprocreate 11 – tumour 421 prosthesis re-exploration 494 RNA, see ribonucleic acid Sertoli function 245 proteus 221 RNASEL, see ribonuclease L gene serum proto-oncogene 363 Robertsonian translocation 463 – SHBG level 245 PSCA, see prostatestemcellantigen ROS, see reactive oxygen species – testosterone 241 pseudogynaecomastia 225, 227 Rosewater syndrome 310 sex pseudohermaphroditism RPLND, see nerve-sparing retroperito- – chromosome 467 –female23 neal lymph node dissection – – abnormality 463 –male23 RRM, see RNA recognition motif ––aneuploidy 474 PSMA, see prostate-specific membrane RTE, see rear tip extender – hormone binding globulin (SHBG) antigen 566 psoriasis vulgaris 195 sagging mouth corner 629 – ratio 318 PSV, see peak systolic velocity salazosulfapyridine 53 –selection11 psycho-sexology 601 salix 569 – steroid 551 pubertal development 532 scatter factor 324 – therapy 600 Subject Index 643 sex-determining region of the Y chro- – – of normally fertile men 42 SRY, see sex-determining region of the mosome (SRY) 268, 306 – – subfertile group 42 Y chromosome sex-hormone binding globulin – chromosomal abnormalities 474 SRY-related HMG-BOX gene 9 (SHBG) 245, 411 – concentration 383, 388 (SOX9) 269 sexual – counting 153, 387 SSM, see superficial spreading melano- – ambiguity 271 – cryopreservation 188, 501, 586, ma – counselling 599 604, 608 SSRI, see selective serotonin uptake in- – couple collusion 109 – cytomorphological analysis 398 hibitor – desire 108 – deformity index 396 Stamey-Meares four-glass test 218, – development 305 –DNA 219 – deviance, psychotherapy 112 – – damage 59 STAR, see steroidogenic acute regulato- – differentiation 19, 23, 266 – – strand breakages 474 ry – dysfunction 108, 601 – donation 607 STD, see sexually transmitted disease – – ageing 532 – Düsseldorf classification 398 steroid 5 [ -reductase 2 (SRD5A2) 270 – – behavioural therapy 600 –functiontests389 steroid hormone 391 – – male infertility 35 – genetic abnormalities 474 steroidogenesis 259, 295 – – mechanical causes 361 – granulomas 182 steroidogenic – – urethrography 102 – immobilization test (SIT) 48 –acuteregulatory(STAR)309 – – urethroscopy 102 –migration300 – factor 1 (SF-1) 268, 308 –intercourse – mitochondria 303 streptococcus (S.) spp. 403 – – difficulties 374 – morphology 399 styrene 353 – – timing 374 – motility 42, 48, 383, 388 subtorsion 150 – masochism 111 – orchiectomy 185 suicide gene therapy 594 –medicine602 –productionindex34 sulfasalazine 54 – sadism 111 – quality 5, 40 superficial spreading melanoma – stimulation 109, 361 – RNA 303 (SSM) 234 sexually transmitted disease (STD) –separation11 superoxide dismutase (SOD) 342 82, 123, 125, 127, 218, 327 –transport54 surrogacy 12 – screening 608 – vaccine 122 Sutherland-Haan syndrome 308 SF-1, see steroidogenic factor 1 – viability 385 Swyer syndrome 307 shaving 624 spermatic syndrome SHBG, see sex hormone binding globu- – cord 137, 261 – 9+0 399 lin – vein 262 – X 251, 254 sheperd’s hook-shaped catheter 451 spermatocele 181, 445 syphilis 331 short tail syndrome 399 spermatogenesis 33, 49, 259, 272, 333, shunt surgery 168 520 Tcell 294 silastic prosthesis 147 – apoptosis 278 tadalafil 88, 528, 529 sildenafil 37, 88, 90, 254, 375, 528, 529 – efficiency 279 tail abnormality 386 silicone catheter 166 –highfever373 tamoxifen 8, 30, 79, 230, 239, 240, Sims-Huhner test 45 – infertility 279 246, 518, 519 SIT, see sperm immobilization test – medical treatments 373 tamsulosin 540, 566 skin – vessel-induced damage 341 TAT, see tray agglutination test – bridge 207 spermatogonia 274, 333 TDF, see testis determining factor – collagen 623 spermatozoa 31, 43, 47, 69, 261, 383, TDS, see testicular dysgenesis syn- –disease 502, 507 drome – – areola mammae 232 –abnormal53 TEFNA, see testicular fine needle aspi- – – nipple 232 – agglutination 385 ration –elastosis626 – amorphous head 386 teratoma 430 – photoageing 626 – cinematographic technique 389 teratozoospermia 31, 41, 77 – sensitivity 623 – double head 386 – index 396 smegma 205 – duplicate head 386 terminal dribble 214 Smith-Fineman syndrome 308 – HIV-free 131 TESE, see testicular sperm extraction smoking 60 – ideally shaped 386 – during pregnancy 349 – motile 50, 116 – innervation 171 smooth muscle – multipleexposurephotography – position and axis 377 – contraction 283 method 388 testicular – relaxation 283 – nonmotile 116 –artery 260 SOD, see superoxide dismutase – pear-shaped head 386 – atrophy 151, 153 soft tissue augmentation 631 – pin head 386 – biopsy 54, 149, 454, 455 solitary testis 150 –pyriform386 – blood vessel 489 somatic mutation 362 – round head 386 – cancer 55, 59, 155, 183, 319, 368, 429, SOX9, see SRY-related HMG-BOX gene 9 – with a tapering head 386 441, 499, 588, 604, 619 soya isoflavone 566 sperm-egg interaction 54 – – sperm storage 372 sperm spermiogenesis 57, 274 – cyst 429 – aster 301 spermMar test 386 – damage 155 – banking 187 spongiosum 167 – dysfunction 408 – cell aneuploidy 354 squamous cell carcinoma 193 – dysgenesis syndrome (TDS) 307, –characteristic SRD5A2, see steroid 5 [ -reductase 2 316 644 Subject Index

– fine needle aspiration (TEFNA) 455 topical steroid 210 – – defect 445 – germ cell cancer (TGCC) 183 torsion – dartos 261 – germ cell tumour (TGCT) 368, 481 – appendages 149 – vaginalis 135, 148, 162, 179, 484 – hypoxia 155 – epididymal 135 turgid cavernosum 168 – injury 162 – extravaginal 137, 141, 149 Turner syndrome 267, 307 – intraepithelial neoplasia (TIN) 454 – intermittent 136, 150 TURP, see transurethral resection of –lump375 – intravaginal 135, 136, 141 the prostate – microlithiasis 428 – mesorchial 135 tyrosine kinase receptor gene 482 – pain 375 – neonatal 137, 140, 143 – – acute 172 – of an intra-abdominal testis 150 ubiquitin C-terminal hydrolase 472 – – chronic 172 – of appendages 136 ultradian fluctuation 409 – – neuropathic syndromes 170 – of the testicular appendage 139, ultrasonography 425 – prosthesis 619 140, 143 uncircumcision 210 –regressionsyndrome141 – of the testis 134, 145 undescended testis (UT) 137, 311, –salvagerate152 – – salvage rates 151 343, 488 – scar 431 – postnatal 143 urethral – sperm extraction (TESE) 49, 306, –prenatal143 –meatus165 439, 454, 582, 589 – subacute 136, 150 – stricture 543 – torsion 66, 134, 138, 342 total PSA (tPSA) 417 urethritis 328, 330, 44 – – cooling 147 total serum T 241 urethrocystoscopy 537, 539 ––ultrasound 442 total testosterone 409 urethroplasty 101 – trauma 66, 136, 445 tPSA, see total PSA urinalysis 143, 537 ––ultrasound 444 trabecular tissue relaxation 339 urinary –tumour transferrin 391 – gonadotropin 517 – – serum markers 184 transforming growth factor-b 296 –tract – volume 378, 426 trans-Golgi complex 274 ––anatomy 471 testis 259 transient secondary hypogonadism ––infection 209 – carcinoma-in-situ 187 57 uroflowmetry 537 – determining factor (TDF) 307 transrectal ultrasonography (TRUS) – measurement 538 – immune cells 292 83, 214, 425 urogenital – infection 296 transsexualism 19, 605 – cancer 362 – inflammation 296 – female-to-male 22 –infection402 – tumour 155 – hormonal treatment 20 urticaria 199 testolactone 28, 518 – male-to-female 22 UT, see undescended testis testosterone 28, 70, 87, 121, 259, 340, – real life test 524 utricular cyst 434, 435, 440 358, 516, 622 transurethral –buciclate521 –microwavetherapy(TUMT)541 vaccine 121 –calculator409 – needle ablation (TUNA) 541 vacuum – decreased serum 243 – resection of the prostate (TURP) –erectiondevice530 – derivatives 517 87, 254, 539 –therapy90 – effects in the elderly 553 – thermo therapy (TUMT) 254 valsalva manoeuvre 448, 449, 451, – enanthate 520 trapped penis 620 512, 514 – free 409 traumatic AV fistulae 88 vanishing testis 141 – levels 243 tray agglutination test (TAT) 48 – syndrome 309 –sideeffects22 treponema (T.) pallidum 402 vannas scissor 504 – supplementation 551 – treponema-specific test 402 vardenafil 88, 528, 529 – total 409 triangulation intussusception 504, varicocele 30, 34, 45, 68, 340, 438, – undecanoate 517, 519, 521, 552 505, 507, 508 439, 449 testosterone-induced masculiniza- trichomonas vaginalis 330, 404 – embolization 510 tion 531 trichomoniasis 192, 331 – imaging 447 tetracycline 54 TRUS, see transrectal ultrasonography –ligation175 TGCC, see testicular germ cell cancer TSG, see tumour suppressor gene – recurrent 452 TGCT, see testicular germ cell tumour tuberculin syringe 512 – superselective sclerotherapy 514 [ -thalassaemia-mental-retardation-X- tuberculosis 60 vasa linked (ATRX) 308 tubular – deferentia 379, 489 Thayer-Martin selective medium 402 – fibrosis 297 – efferentia 504 thermal injury 632 – sclerosis 83 vascular thermography 69, 448 tumour – disease 92 thermotherapy 541 – gonadotrophin-secreting 28 – penile dysfunction 339 three-dimensional conformal radiation – marker 415 vasectomy 47, 55, 114, 182 therapy (3D-CRT) 545 – necrosis factor (TNF) 391 – complications 499 thyroid hormone replacement 315 ––alpha(TNF[ ) 220, 295 – consent form 499 TIN, see testicular intraepithelial neo- – of the male genital tract 439 – ligaclips 497 plasia – suppressor gene (TSG) 364 – no scalpel technique 496 tissue research 14 TUMT, see transurethral thermo therapy –reversal119 – categories of identification 14 TUNA, see transurethral needle ablation – sperm storage 499 TNF, see tumour necrosis factor tunica – tissue plane technique 496 tobacco smoke 349 – albuginea 147, 162, 164, 259, 265 – wreking technique 495 Subject Index 645 vasoepididymostomy 119, 120, 500, vinca minor 565 X-chromosome 465 502, 503 virus-mediated oncolysis 595 xenobiotic 365 – complications 508 viscosity 382 xeno-oestrogen 316, 317 vasovasostomy 55, 119, 500, 502, 503 vitamin X-linked – complications 508 – A 624 –disorder466 vein patch 96 – C 567, 625 – variety 314 vena dorsalis penis profunda 265 – D 368 Xp pseudoautosomal region 466 venae emissariae 265 – E 625 venography 451, 512 von Hippel-Lindau disease 181 Y chromosome 469 –diagnostic510 voyeurism 111 – gene 466 venous vulvodynia 223 Ydeletion 83 – leakage 70, 86, 339 VUR, see vesico-ureteric reflux Y microdeletion 65, 469 ––surgery 90 yeast 404 – sclerosis 70 WAGR syndrome 268, 308 Young’s syndrome 78 – thromboembolism 526 WBC, see white blood cell verapamil 54 620 Z chromosome 308 vesico-ureteric reflux (VUR) 209 white blood cell (WBC) 323 zinc 567, 574 vesiculitis 72, 74 Wilm’s tumour 1 gene (WT1) 268, –therapy58 – epididymo-prostato 406 307 zona pellucida 301 – prostato-seminal 406 Wolffian cyst 436 zona-free hamster oocyte test 50 Viagra 88 WT1, see Wilm’s tumour 1 gene Zoon’s balanitis 193, 194, 206 8ZQV\QVOIVL*QVLQVO";\ÛZ\b/UJ0?ÛZbJ]ZO